Dramatic ibrutinib efficacy in Schnitzler syndrome with indolent lymphoma
Claves F, et al.
J Clin Immunol · 2021
Key Findings
- ●Dramatic ibrutinib efficacy in Schnitzler syndrome with indolent lymphoma
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: pmid-33871787DOI: 10.1007/s10875-021-01048-0PMID: 33871787